Commentary: Mark Cuban won’t fix our drug pricing problem
by Peter Neumann, Joshua Cohen and Daniel Ollendorf, Los Angeles Times
Jul 13, 2022
3 minutes
Mark Cuban, the billionaire “Shark Tank” celebrity and Dallas Mavericks owner, is getting attention again — this time for his Mark Cuban Cost Plus Drug Co., which seeks to reduce prescription drug prices for Americans. A new study finds that Medicare could have saved $3.6 billion in 2020 if it had paid Mark Cuban drug prices.
This finding has been hailed as big news, reflecting the fact that Americans reliably consider prescription drug costs a high-priority issue. CBS reported that Cuban aims to turn the industry “upside down.”
You’re reading a preview, subscribe to read more.
Start your free 30 days